Naloxone rarely administered by layperson in opioid deaths

Naloxone rarely administered by layperson in opioid deaths

(HealthDay)—From July 2016 to June 2017, bystanders were documented in 44 percent of opioid overdose deaths, but naloxone was rarely administered by a layperson, according to a study published Aug. 31 in Morbidity and Mortality Weekly Report.

Christine L. Mattson, Ph.D., from the Centers for Disease Control and Prevention (CDC), and colleagues used data from 11 states participating in the CDC's Enhanced State Opioid Overdose Surveillance program to describe overdose deaths among those testing positive for prescription opioids (e.g., oxycodone and hydrocodone), illicit opioids (e.g., heroin, illicitly manufactured fentanyl, and fentanyl analogs), or both prescription and illicit opioids.

From July 2016 through June 2017, the researchers identified 11,884 opioid overdose deaths, in which 17.4 percent of decedents tested positive for prescription opioids only, 58.7 percent for illicit opioids only, and 18.5 percent for both prescription and illicit opioids. In the month preceding the fatal , approximately one in 10 decedents had been released from an institutional setting. In 44 percent of the deaths, bystanders were reportedly present, but naloxone was rarely administered by a layperson.

"Consistent with other emerging evidence and recommendations, these data suggest prevention efforts should prioritize naloxone distribution to persons misusing opioids or using high-dosage and to their family members and friends," conclude the authors.


Explore further

Opioid overdoses in ERs up 30 percent as crisis worsens

More information: Abstract/Full Text

Copyright © 2018 HealthDay. All rights reserved.

Citation: Naloxone rarely administered by layperson in opioid deaths (2018, September 10) retrieved 18 July 2019 from https://medicalxpress.com/news/2018-09-naloxone-rarely-layperson-opioid-deaths.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more